766
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Effect of lithium salts on lactate dehydrogenase, adenylate kinase, and 1-phosphofructokinase activities

, , , , , & show all
Pages 551-556 | Received 02 Sep 2009, Accepted 22 Sep 2009, Published online: 02 Jul 2010

References

  • Russell P, Williams A, Marquez K, Hua T, Ehya F, Hardamon C, et al. Effect of ammonium, sodium, and potassium ions on rabbit muscle phosphofructokinase-1 and adenylate kinase activities, J Enzyme Inhib Med Chem 2009;24;1–7.
  • Schou M, Juel-Nielsen N, Stromgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 1954;17:250–60.
  • Cade J. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949;2:349–52.
  • Johnson FN, Cade JFJ. The Historical Background to Lithium Research and Therapy. London: Academic Press, 1975:9–22.
  • Russell PJ, Williams A, Gapuz D. Inhibition of rabbit muscle adenylate kinase by vitamin C. Biochem Biophys Res Commun 1997;233:386–8.
  • Russell PJ, Williams A, Austin TA. Inhibition of rabbit muscle isozymes by vitamin C. J Enzyme Inhib 2000;15:283–96.
  • Russell PJ, Williams A, Amador X, Vargas R. Aldolase and actin protect rabbit muscle lactate dehydrogenase from ascorbate inhibition. J Enzyme Inhib 2004;19:91–8.
  • Russell PJ, Williams A, Abbott A, DeRosales B, Vargas R. Characteristics of rabbit muscle adenylate kinase inhibition by ascorbate. J Enzyme Inhib Med Chem 2006;21:61–7.
  • Russell P, Williams A, Marquez K, Tahir Z, Hosseinian B, Lam K. Some characteristics of rabbit muscle phosphofructokinase-1 inhibition by ascorbate. J Enzyme Inhib Med Chem 2008;23:411–17.
  • Kemp RG, Wood W, eds. Phosphofructokinase from rabbit skeletal muscle. Methods Enzymol 1975;42C:71–7.
  • Morrissey JH. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem 1981;117:307–10.
  • Adam H. Methods of Enzymatic Analysis. New York:Academic Press, 1963:145–52.
  • Anderson RL, Hanson TE, Sapico VL. D-Fructose-1-phosphate kinase A. aerogenes. J Biol Chem 1969;244:6280–8.
  • Wilson K, Walker J. Principles and Techniques of Practical Biochemistry. Cambridge: Cambridge University Press, 2001:230.
  • Bradford MM. Determination of protein concentration in the manufacture and characterization of biopharmaceuticals. Anal Biochem 1976;72:248–54.
  • Struneck A, Patočka J, Sarek M. How does lithium mediate its therapeutic effects? J Appl Biomed 2005;3:25–35.
  • Goldberg H, Clayman P, Skorecki K. Mechanism of Li inhibition of vasopressin-sensitive adenylate cyclase in cultured renal epithelial cells. J Physiol 1988;255:F995–1002.
  • Kajda PK, Birch NJ. Lithium inhibition of phosphofructokinase. J Inorgan Chem 1981;14:275–8.
  • Nordenberg J, Kaplansky M, Beery E, Klein S, Beitner R. Effects of lithium on the activities of phosphofructokinase and phosphoglucomutase and on glucose-1,6-diphosphate levels in rate muscles and liver. Biochem Pharm 1982;31:1025–31.
  • Mann L, Heldman E, Shabltiel G, Belmaker RH, Agam G. Lithium preferentially inhibits adenylyl cyclase V and VII isoforms. Int J Neuropsychopharmacol 2008;11:533–9.
  • López-Coronado JM, Bellés JM, Lesage Dagger F, Serrano R, Rodríguez PL. A novel mammalian lithium-sensitive enzyme with a dual enzymatic activity, 3’-phosphoadenosine 5’-phosphate phosphatase and inositol-polyphosphate 1-phosphatase. J Biol Chem 1999;274:16034–9.
  • Hallcher LM, Sherman WR. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 1980;255:10896–901.
  • Jope RS. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 2003;24:441–3.
  • Beyaert R, Vanhaesebroeck B, Suffys P. Van Roy F, Fiers W. Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo. Proc Natl Acad Sci USA 1989;86:9494–8.
  • King TD, Bijur GN, Jope RS. Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3β and attenuated by lithium. Brain Res 2001;919:106–14.
  • Zhang F, Phiel CJ, Spece L, Gurvich N, Klein PS. Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. J Biol Chem 2003;278:33067–77.
  • Rodriguez-Gil JE, Fernandez JM, Barbera A, Guiovart JJ. Lithium’s effects on rat liver glucose metabolism in vivo. Arch Biochem Biophys 2000;375:377–84.
  • Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996;93:8455–9.
  • Centeno F, Mora A, Fuentes JM, Soler G, Claro E. Partial lithium-associated protection against apoptosis induced by C2-ceramide in cerebellar granule neurons. Neuroreport 1998;9:4199–203.
  • Schotte P, Van Loo G, Carpentier I, Vandenabeele P, Beyaert R. Lithium sensitizes tumor cells in an NF-κB-independent way to caspase activation and apoptosis induced by tumor necrosis factor (TNF). Evidence for a role of the TNF receptor-associated death domain protein. J Biol Chem 2001;276:25939–45.
  • Hongisto V, Smeds N, Brecht S, Herdegen T, Courtney MJ, Coffey ET. Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3. Mol Cell Biol 2003;23:6027–36.
  • De Sarno P, Li X, Jope RS. Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium. Neuropharmacology 2002;43:1158–64.
  • Bijur GN, De Sarno P, Jope RS. Glycogen synthase kinase-3β facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J Biol Chem 2000;275:7583–90.
  • Jope RS, Bijur GN. Mood stabilizers, glycogen synthase kinase-3β and cell survival. Mol Psychiatry 2002;7(Suppl. 1):S35–45.
  • Chuang DM, Chen RW, Chalecka-Franaszek E, Ren M, Hashimoto R, Senatorov V, et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord 2002;4:129–36.
  • Alvarez G, Munoz-Montano JR, Satrustegui J, Avila J, Bogonez E, Diaz-Nido J. Lithium protects cultured neurons against β-amyloid-induced neurodegeneration. FEBS Lett 1999;453:260–4.
  • Wei H, Leeds PR, Qian Y, Wei W, Chen R, Chuang D. β-Amyloid peptide-induced death of PC12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment. Eur J Pharmacol 2000;392:117–23.
  • Nonaka S, Chuang DM. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport 1998;9:2081–4.
  • Ren M, Senatorov VV, Chen RW, Chuang DM. Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proc Natl Acad Sci USA 2003;100:6210–15.
  • Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996;93:8455–9.
  • Beyaert R, Heyninck K, De Valck D, Boeykens F, van Roy F, Fiers W. Enhancement of tumor necrosis factor cytotoxicity by lithium chloride is associated with increased inositol phosphate accumulation. J Immunol 1993;151:291–300.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.